CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 4 Open-market sale CFO and CBO sold 3,435 shares at $11.10 ($38,129)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale President and Chief Executive sold 16,851 shares at $9.11 ($153,513)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 3,703,703 shares at $8.10 ($29,999,994)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale CFO and CBO sold 6,307 shares at $7.75 ($48,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 25 · 496 filings